Point72 Asset Management
GNMK

Point72 Asset Management’s GenMark Diagnostics, Inc GNMK Stock Holding History

Point72 Asset Management’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-355,680
Closed -$1.71M – 1206
2019
Q4 		$1.71M Buy
+355,680
New +$1.96M 0.01% 642
2017
Q3 		– Sell
-201,000
Closed -$2.38M – 1121
2017
Q2 		$2.38M Buy
+201,000
New +$2.57M 0.01% 622

Other funds holding GNMK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Point72 Asset Management's GNMK Position: Q1 2020 in Review

Point72 Asset Management sold out of GenMark Diagnostics, Inc (GNMK) in Q1 2020, closing a stake of 355,680 shares — an estimated $1.71M sold.

Point72 Asset Management first reported a position in GNMK in Q2 2017 and held it in 2 quarters. The position peaked at $2.38M in Q2 2017. 110 funds tracked by Wall St. Rank hold GNMK as of Q1 2020.

  • Point72 Asset Management reported no remaining GenMark Diagnostics, Inc position as of Q1 2020 after selling out during the quarter.
  • Point72 Asset Management sold 355,680 GenMark Diagnostics, Inc shares in Q1 2020, an estimated $1.71M.
  • Point72 Asset Management first reported a position in GenMark Diagnostics, Inc in Q2 2017 and held it in 2 quarters.
  • Point72 Asset Management's GenMark Diagnostics, Inc position peaked at $2.38M in Q2 2017.
  • 110 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q1 2020.

Based on Point72 Asset Management's 13F filing for Q1 2020, filed 15 May 2020.